サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1694801

産後うつ病の世界市場レポート 2025年

Postpartum Depression Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
産後うつ病の世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

産後うつ病の市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR32.4％で494億米ドルに成長します。予測期間の成長は、遠隔医療サービス、薬理学的進歩、妊産婦のメンタルヘルスに関する法律、メンタルヘルス従事者の拡大に起因しています。予測期間の主な動向には、統合ケアモデル、ピアサポートプログラム、周産期メンタルヘルスアプリ、メンタルヘルススクリーニングツールなどがあります。

産後うつ病症例の増加が産後うつ病市場の成長を促進すると予測されます。産後うつ病とは、出産後に起こる過剰な心配や精神的苦痛を指し、しばしば身体的症状を伴います。産後うつ病は不安症と併発するのが一般的で、症状は産後1年間のどの時点からでも始まる可能性があります。産後うつ病の治療法には、トークセラピーやメンタルヘルスカウンセリングとして知られる心理療法、薬物療法、またはその両方の組み合わせがあり、これが市場の成長に寄与しています。例えば、バージニア大学医学部（UVA SoM）が2022年2月に110万人の母親を対象に実施した調査によると、初産婦、25歳未満、双子の母親が産後うつ病のリスクが最も高いことが明らかになりました。年齢層別では、18～24歳の女性の産後うつ病症状の自己申告率が最も高く、10％でした。双子の母親は、単胎児の母親（8.3％）に比べ、症状の割合が高くなりました（11.3％）。このように、産後うつ病の罹患率の増加は、産後うつ病市場の成長を促進すると思われます。

出産数の増加は、産後うつ病市場の成長を加速させると予想されます。出産とは、赤ちゃんが母親の子宮から、通常は腟を通して生まれる過程を指します。この状態は出産後の女性に影響を与える一般的な精神衛生問題であるため、出産の増加は産後うつ病市場に貢献しています。産後うつ病は、悲しみ、不安、疲労、赤ちゃんとの絆の難しさなど、さまざまな症状を引き起こす可能性があります。例えば、米国疾病予防管理センター（CDC）が2023年1月に発表した報告書によると、米国における出生登録件数は前年比1％増の366万4,292件に達しました。このため、出産件数の増加が産後うつ病市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の産後うつ病市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の産後うつ病市場：成長率分析
  • 世界の産後うつ病市場の実績：規模と成長、2019～2024年
  • 世界の産後うつ病市場の予測：規模と成長、2024～2029年、2034年
  • 世界の産後うつ病総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の産後うつ病市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 産後ブルース
  • 産後不安
  • 産後強迫性障害
  • 産後パニック障害
  • 産後心的外傷後ストレス障害
  • 産後精神病
  • その他
  • 世界の産後うつ病市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
  • 心理療法
  • 薬剤
  • サプリメント
  • その他
  • 世界の産後うつ病市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口
  • 非経口
  • その他
  • 世界の産後うつ病市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他
  • 世界の産後うつ病市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
  • 病院
  • 専門クリニック
  • ホームケア
  • その他
  • 世界の産後うつ病市場：産後ブルースのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 軽度の感情障害
  • 短期的な気分の変動
  • 世界の産後うつ病市場：産後不安のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 全般性不安障害（GAD）
  • パニック発作
  • 世界の産後うつ病市場：産後強迫性障害のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 侵入思考
  • 強迫的行動
  • 世界の産後うつ病市場：産後パニック障害のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 突然のパニック発作
  • 身体症状
  • 世界の産後うつ病市場：産後心的外傷後ストレス障害（PTSD）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 出産に対するトラウマ反応
  • フラッシュバックと不安
  • 世界の産後うつ病市場：産後精神病のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 幻覚
  • 激しい気分の変動
  • 世界の産後うつ病市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 混合性気分障害
  • 産後合併症

第7章 地域別・国別分析

  • 世界の産後うつ病市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界の産後うつ病市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 産後うつ病市場：競合情勢
  • 産後うつ病市場：企業プロファイル
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Sanofi SA
  • Bristol Myers Squibb Co.
  • AstraZeneca plc
  • GlaxoSmithKline LLC
  • Takeda Pharmaceutical Company
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Moderna Inc.
  • BioNTech SE
  • Viatris Inc.
  • Northwell Health
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 産後うつ病市場2029：新たな機会を提供する国
  • 産後うつ病市場2029：新たな機会を提供するセグメント
  • 産後うつ病市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28778

Postpartum depression (PPD) is a mood disorder that affects some women after giving birth and often goes undiagnosed for extended periods. It is characterized by feelings of sadness, hopelessness, and a loss of interest or pleasure in activities once enjoyed.

The main types of postpartum depression include postpartum blues, postpartum anxiety, postpartum obsessive-compulsive disorder, postpartum panic disorder, postpartum post-traumatic stress disorder, postpartum psychosis, and others. Postpartum blues is a common but self-limiting condition that occurs shortly after childbirth, featuring symptoms such as mood swings, irritability, and tearfulness. Treatment for postpartum depression involves various approaches, including psychotherapy, medication, supplements, and other therapeutic interventions. These treatments can be administered in different ways, such as orally, through injections, and more. Postpartum depression remedies are available through various distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others. They are used by a range of end-users, including hospitals, specialty clinics, home-care settings, and others.

The postpartum depression market research report is one of a series of new reports from The Business Research Company that provides postpartum depression market statistics, including postpartum depression industry global market size, regional shares, competitors with a postpartum depression market share, detailed postpartum depression market segments, market trends and opportunities and any further data you may need to thrive in the postpartum depression industry. This postpartum depression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The postpartum depression market size has grown exponentially in recent years. It will grow from $12.15 billion in 2024 to $16.09 billion in 2025 at a compound annual growth rate (CAGR) of 32.4%. The growth in the historic period can be attributed to maternal mental health awareness, research advancements, public health initiatives, increased screenings.

The postpartum depression market size is expected to see exponential growth in the next few years. It will grow to $49.4 billion in 2029 at a compound annual growth rate (CAGR) of 32.4%. The growth in the forecast period can be attributed to telehealth services, pharmacological advancements, maternal mental health legislation, mental health workforce expansion. Major trends in the forecast period include integrated care models, peer support programs, perinatal mental health apps, mental health screening tools.

An increase in postpartum depression cases is expected to drive the growth of the postpartum depression market. Postpartum depression refers to excessive worry and emotional distress that occurs after childbirth, often accompanied by physical symptoms. It is common for postpartum depression to coexist with postnatal depression and anxiety, with symptoms potentially starting at any point during the first year after birth. Treatment options for postpartum depression include psychotherapy, also known as talk therapy or mental health counseling, medications, or a combination of both, which contributes to the market's growth. For example, a survey of 1.1 million mothers conducted by the University of Virginia School of Medicine (UVA SoM) in February 2022, found that first-time mothers, those under 25, and mothers of twins were most at risk for postpartum depression. Among age groups, women aged 18-24 had the highest self-reported rate of postpartum depression symptoms at 10%. Mothers of twins had a higher rate of symptoms (11.3%) compared to those with single children (8.3%). As such, the rising incidence of postpartum depression will drive the growth of the postpartum depression market.

The growing number of childbirths is expected to accelerate the growth of the postpartum depression market. Childbirth is the process in which a baby is born from the mother's uterus, usually through the vaginal canal. The increase in childbirths contributes to the postpartum depression market, as this condition is a common mental health issue affecting women following delivery. Postpartum depression can lead to various symptoms, such as sadness, anxiety, fatigue, and difficulty bonding with the baby. For instance, a report published by the Centers for Disease Control and Prevention (CDC) in January 2023 indicated a 1% rise in registered births in the United States, reaching a total of 3,664,292 births compared to the previous year. Therefore, the rising number of childbirths is driving the expansion of the postpartum depression market.

Companies active in the postpartum depression market are focusing on innovation to maintain their market presence. The need for faster-acting therapies and innovative care delivery methods for postpartum depression has arisen due to the limited treatment options available. For example, in February 2023, Biogen Inc., a U.S.-based biotechnology company, and Sage Therapeutics Inc., a U.S.-based biopharmaceutical company, announced the acceptance of a new drug application (NDA) by the United States Food and Drug Administration (FDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication being investigated as a 14-day, once-daily, fast-acting oral therapy for individuals with MDD and PPD. As a neuroactive steroid, zuranolone functions as a positive allosteric modulator of GABA-A receptors, offering a unique mechanism of action. It is designed to rapidly reset dysregulated neural networks to aid in restoring brain function and, in turn, influence the brain networks responsible for mood, arousal, behavior, and cognition.

In December 2022, Biogen Inc. and Sage Therapeutics Inc. joined forces for an undisclosed amount, aimed at the development and commercialization of drugs for major depressive disorder (MDD), postpartum depression (PPD), as well as other mental disorders, essential tremor, and various neurological conditions. Sage Therapeutics Inc. specializes in the development of therapies for neurological conditions such as depression, PPD, neurology, and neuropsychiatric disorders. This collaboration enhances the prospects for advancing treatments in the field of mental health and neurology.

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the postpartum depression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The postpartum depression market consists of revenues earned by entities by providing services such as medications, psychotherapy (cognitive behavioral therapy) and support group participation. The market value includes the value of related goods sold by the service provider or included within the service offering. The postpartum depression market also includes the sales of medications such as Selective serotonin reuptake inhibitors (SSRIs), Serotonin and norepinephrine reuptake inhibitors (SNRIs), Bupropion and Tricyclic antidepressants (TCAs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postpartum Depression Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postpartum depression market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for postpartum depression ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postpartum depression market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Types: Postpartum Blues; Postpartum Anxiety; Postpartum Obsessive Compulsive Disorder; Postpartum Panic Disorder; Postpartum Post-Traumatic Stress Disorder; Postpartum Psychosis; Other Types
  • 2) By Treatment: Psychotherapy; Medication; Supplements; Other Treatments
  • 3) By Route of Administration: Oral; Parenteral; Other Route Of Administration
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
  • 5) End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Subsegments:
  • 1) By Postpartum Blues: Mild Emotional Disturbances; Short-term Mood Swings
  • 2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD); Panic Attacks
  • 3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts; Compulsive Behaviors
  • 4) By Postpartum Panic Disorder: Sudden Panic Attacks; Physical Symptoms
  • 5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth; Flashbacks And Anxiety
  • 6) By Postpartum Psychosis: Hallucinations; Severe Mood Swings
  • 7) By Other Types: Mixed Mood Disorders; Comorbid Conditions With Postpartum
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Postpartum Depression Market Characteristics

3. Postpartum Depression Market Trends And Strategies

4. Postpartum Depression Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Postpartum Depression Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Postpartum Depression PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Postpartum Depression Market Growth Rate Analysis
  • 5.4. Global Postpartum Depression Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Postpartum Depression Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Postpartum Depression Total Addressable Market (TAM)

6. Postpartum Depression Market Segmentation

  • 6.1. Global Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Postpartum Blues
  • Postpartum Anxiety
  • Postpartum Obsessive Compulsive Disorder
  • Postpartum Panic Disorder
  • Postpartum Post-Traumatic Stress Disorder
  • Postpartum Psychosis
  • Other Types
  • 6.2. Global Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Psychotherapy
  • Medication
  • Supplements
  • Other Treatments
  • 6.3. Global Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administration
  • 6.4. Global Postpartum Depression Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Other Distribution Channels
  • 6.5. Global Postpartum Depression Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users
  • 6.6. Global Postpartum Depression Market, Sub-Segmentation Of Postpartum Blues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mild Emotional Disturbances
  • Short-term Mood Swings
  • 6.7. Global Postpartum Depression Market, Sub-Segmentation Of Postpartum Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Generalized Anxiety Disorder (GAD)
  • Panic Attacks
  • 6.8. Global Postpartum Depression Market, Sub-Segmentation Of Postpartum Obsessive Compulsive Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intrusive Thoughts
  • Compulsive Behaviors
  • 6.9. Global Postpartum Depression Market, Sub-Segmentation Of Postpartum Panic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sudden Panic Attacks
  • Physical Symptoms
  • 6.10. Global Postpartum Depression Market, Sub-Segmentation Of Postpartum Post-Traumatic Stress Disorder (PTSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trauma Response To Childbirth
  • Flashbacks And Anxiety
  • 6.11. Global Postpartum Depression Market, Sub-Segmentation Of Postpartum Psychosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hallucinations
  • Severe Mood Swings
  • 6.12. Global Postpartum Depression Market, Sub-Segmentation Of Other Types, By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mixed Mood Disorders
  • Comorbid Conditions With Postpartum

7. Postpartum Depression Market Regional And Country Analysis

  • 7.1. Global Postpartum Depression Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Postpartum Depression Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Postpartum Depression Market

  • 8.1. Asia-Pacific Postpartum Depression Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Postpartum Depression Market

  • 9.1. China Postpartum Depression Market Overview
  • 9.2. China Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Postpartum Depression Market

  • 10.1. India Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Postpartum Depression Market

  • 11.1. Japan Postpartum Depression Market Overview
  • 11.2. Japan Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Postpartum Depression Market

  • 12.1. Australia Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Postpartum Depression Market

  • 13.1. Indonesia Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Postpartum Depression Market

  • 14.1. South Korea Postpartum Depression Market Overview
  • 14.2. South Korea Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Postpartum Depression Market

  • 15.1. Western Europe Postpartum Depression Market Overview
  • 15.2. Western Europe Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Postpartum Depression Market

  • 16.1. UK Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Postpartum Depression Market

  • 17.1. Germany Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Postpartum Depression Market

  • 18.1. France Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Postpartum Depression Market

  • 19.1. Italy Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Postpartum Depression Market

  • 20.1. Spain Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Postpartum Depression Market

  • 21.1. Eastern Europe Postpartum Depression Market Overview
  • 21.2. Eastern Europe Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Postpartum Depression Market

  • 22.1. Russia Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Postpartum Depression Market

  • 23.1. North America Postpartum Depression Market Overview
  • 23.2. North America Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Postpartum Depression Market

  • 24.1. USA Postpartum Depression Market Overview
  • 24.2. USA Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Postpartum Depression Market

  • 25.1. Canada Postpartum Depression Market Overview
  • 25.2. Canada Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Postpartum Depression Market

  • 26.1. South America Postpartum Depression Market Overview
  • 26.2. South America Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Postpartum Depression Market

  • 27.1. Brazil Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Postpartum Depression Market

  • 28.1. Middle East Postpartum Depression Market Overview
  • 28.2. Middle East Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Postpartum Depression Market

  • 29.1. Africa Postpartum Depression Market Overview
  • 29.2. Africa Postpartum Depression Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Postpartum Depression Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Postpartum Depression Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Postpartum Depression Market Competitive Landscape And Company Profiles

  • 30.1. Postpartum Depression Market Competitive Landscape
  • 30.2. Postpartum Depression Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Postpartum Depression Market Other Major And Innovative Companies

  • 31.1. Sanofi SA
  • 31.2. Bristol Myers Squibb Co.
  • 31.3. AstraZeneca plc
  • 31.4. GlaxoSmithKline LLC
  • 31.5. Takeda Pharmaceutical Company
  • 31.6. Eli Lilly and Company
  • 31.7. Gilead Sciences Inc.
  • 31.8. Amgen Inc.
  • 31.9. Moderna Inc.
  • 31.10. BioNTech SE
  • 31.11. Viatris Inc.
  • 31.12. Northwell Health
  • 31.13. Teva Pharmaceutical Industries Ltd.
  • 31.14. Regeneron Pharmaceuticals Inc.
  • 31.15. Biogen Inc.

32. Global Postpartum Depression Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Postpartum Depression Market

34. Recent Developments In The Postpartum Depression Market

35. Postpartum Depression Market High Potential Countries, Segments and Strategies

  • 35.1 Postpartum Depression Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Postpartum Depression Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Postpartum Depression Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer